Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation. Okuno T, Arakawa S, Yoshida T, Ohe Y, et al. Lung Cancer 2020;143:95-96.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okuno T, Arakawa S, Yoshida T, Ohe Y, et al. Efficacy of osimertinib in a patient with leptomeningeal metastasis and EGFR uncommon S768I mutation. Lung Cancer 2020;143:95-96.
PMID: 32209253